The proposed project has the overall goal of developing methods and tools, founded on clinical and experimental data, to optimize three- dimensional conformal radiation therapy - with specific reference to understanding and taking advantage of dose-volume effects. The dose-volume response of normal tissues and tumors will be determined, to the extent possible, through the analysis of clinical and experimental data. The data for selected sites will be accumulated from published results and through collaborations with other investigators. The attempt will be made to fit the available data with existing and new models of ours and others. A comprehensive methodology for fitting clinical data which will include an analysis of goodness-of-fit and confidence limits on model parameters will be developed based on the methods of maximum likelihood and resampling statistics. Censored character of the clinical data will be accounted for through modeling the latency periods and dose- survival relationships. This time adjustment is necessary when one fits the model to clinical data with the follow-up times not long enough to reach the plateau level of the recurrence-free or complication-free survival curve. Techniques to pick a set of optimal beam directions and their intensity profiles will be developed. Several biological and physical score functions will be investigated to determine their utility for optimizing dose distributions with intensity modulated beams. The issue of how many (or how few) beam directions are needed for optimal plans will be studied for various sites and score functions. Models of tissue response to radiation will be used to determine the optimal margins for both open and intensity modulated beams. A user-friendly """"""""point-and-click"""""""" interface, including spreadsheets and protocols, to allow a clinician to inspect and fine-tune biological models used in optimizing and/or quantitative assessing treatment plans and to inspect the concordance of the models with clinical judgment will be developed. The optimization package will be implemented on our three- dimensional treatment planning system. New models of the dose-volume response of normal tissues and tumors will be developed if and as dictated by data analysis. The new models will take into account the spatial distribution of function of an organ as determined by various functional studies (e.g. SPECT studies for lung), and correlation of the survival of clonogens or functional subunits and the vitality of the neighboring clonogens/functional subunits. The results of this research will be applied to clinical cases to budge their efficacy. It is expected that the outcome of the proposed research will make the optimization of three-dimensional conformal radiotherapy a compelling part of modem routine treatment planning.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA050628-11
Application #
6076564
Study Section
Radiation Study Section (RAD)
Program Officer
Stone, Helen B
Project Start
1989-09-01
Project End
2000-05-31
Budget Start
1999-06-01
Budget End
2000-05-31
Support Year
11
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Kozin, Sergey V; Niemierko, Andrzej; Huang, Peigen et al. (2008) Inter- and intramouse heterogeneity of radiation response for a growing paired organ. Radiat Res 170:264-7
Yang, Jack Y; Niemierko, Andrzej; Yang, Mary Qu et al. (2008) Analyzing adjuvant radiotherapy suggests a non monotonic radio-sensitivity over tumor volumes. BMC Genomics 9 Suppl 2:S9
Nguyen, Paul L; Taghian, Alphonse G; Katz, Matthew S et al. (2008) Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 26:2373-8
Katz, Angela; Smith, Barbara L; Golshan, Mehra et al. (2008) Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer. J Clin Oncol 26:2093-8
Suit, Herman; Goldberg, Saveli; Niemierko, Andrzej et al. (2007) Secondary carcinogenesis in patients treated with radiation: a review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects. Radiat Res 167:12-42
Katz, Angela; Niemierko, Andrzej; Gage, Irene et al. (2006) Factors associated with involvement of four or more axillary nodes for sentinel lymph node-positive patients. Int J Radiat Oncol Biol Phys 65:40-4
Katz, Angela; Niemierko, Andrzej; Gage, Irene et al. (2006) Can axillary dissection be avoided in patients with sentinel lymph node metastasis? J Surg Oncol 93:550-8
Pieters, Richard S; Niemierko, Andrzej; Fullerton, Barbara C et al. (2006) Cauda equina tolerance to high-dose fractionated irradiation. Int J Radiat Oncol Biol Phys 64:251-7
Taghian, Alphonse G; Assaad, Sherif I; Niemierko, Andrzej et al. (2005) Is a reduction in radiation lung volume and dose necessary with paclitaxel chemotherapy for node-positive breast cancer? Int J Radiat Oncol Biol Phys 62:386-91
Marucci, Laura; Niemierko, Andrzej; Liebsch, Norbert J et al. (2004) Spinal cord tolerance to high-dose fractionated 3D conformal proton-photon irradiation as evaluated by equivalent uniform dose and dose volume histogram analysis. Int J Radiat Oncol Biol Phys 59:551-5

Showing the most recent 10 out of 28 publications